Herbal Monograph
Horsetail
Equisetum arvense L.
Equisetaceae (Equisetales)
Ancient silica-rich pteridophyte for urinary flushing, connective tissue strengthening, and bone support
Overview
Plant Description
Equisetum arvense is a perennial, spore-bearing vascular plant (pteridophyte) belonging to one of the oldest surviving plant lineages on Earth. The genus Equisetum is the sole surviving member of the class Equisetopsida (formerly Sphenopsida), which dates back to the Devonian period (approximately 350-400 million years ago). During the Carboniferous period, ancestors of modern Equisetum (the Calamites) formed vast forests of tree-sized horsetails reaching 30 meters in height, contributing significantly to the coal deposits formed during that era. Today's horsetails are diminutive remnants of this ancient lineage, but they retain the distinctive segmented, hollow-stemmed morphology of their ancestors. E. arvense produces two distinct types of aerial stems from an extensive, deeply penetrating rhizome system: (1) Fertile stems (strobili-bearing) appear in early spring before the vegetative stems. They are unbranched, pale brown to pinkish-buff, 10-25 cm tall, with loose, papery sheaths at each node and a terminal cone-like strobilus (sporangiophore) 1-4 cm long that produces and releases green spores. These fertile stems wither and die back after spore dispersal, typically by late spring. (2) Sterile (vegetative) stems emerge after the fertile stems and persist through the growing season until autumn frost. These are the medicinally used part. They are erect, 20-80 cm tall, bright green, distinctly jointed (articulated) at regular nodes, with a rough, ridged surface due to the high silica content deposited in the epidermal cell walls. Each node bears a whorl of 6-18 slender, ascending, solid, 4-angled lateral branches (giving the characteristic 'bottlebrush' or 'horsetail' appearance). The main stem is hollow with a small central cavity surrounded by a ring of vallecular canals. True leaves are absent; instead, small, tooth-like, dark-tipped scales are fused into sheaths at each node, representing highly reduced microphylls. The entire plant has a characteristic rough, gritty texture when handled, attributable to the silica deposits. The rhizome system is black, wiry, extensively branching, and can penetrate to depths of 1.5-2 meters, making the plant extremely difficult to eradicate once established.
Habitat
Equisetum arvense is a habitat generalist that thrives in moist to wet, disturbed soils. It is most commonly found along roadsides, railway embankments, ditch banks, stream margins, riverbanks, flood plains, moist meadows, pastures, and in cultivated ground where it is often considered a persistent weed. It tolerates a wide range of soil pH (acidic to slightly alkaline) and textures (sandy to clay), though it strongly prefers soils with adequate moisture and good drainage. It is frequently an indicator of high water table or subsurface water movement. The deeply penetrating rhizome system allows it to access water and minerals well below the soil surface, contributing to its mineral-accumulating properties. It is a pioneer colonizer of disturbed and degraded sites, including mine tailings and eroded slopes, where its ability to accumulate and deposit silica in its tissues can contribute to soil stabilization.
Distribution
Equisetum arvense has a vast circumboreal distribution across the temperate and subarctic regions of the Northern Hemisphere. It is native across most of Europe (from Scandinavia and the British Isles south to the Mediterranean region, though less common in the hottest, driest areas), temperate Asia (Russia, China, Japan, Korea, the Himalayas), and North America (from Alaska and northern Canada south throughout the United States, less common in the deep Southeast). It has been introduced and naturalized in parts of the Southern Hemisphere, including New Zealand, southern Australia, and parts of South America. It grows from sea level to alpine elevations (documented up to approximately 2,500 meters in the Alps and 3,000 meters in the Himalayas). Its enormous geographic range and ecological adaptability reflect both its ancient evolutionary origins and its effective vegetative reproduction via rhizomes.
Parts Used
Sterile aerial stems (Equiseti herba)
Preferred: Dried cut herb for infusion or decoction; fluid extract; standardized dry extract (standardized to silicic acid or flavonoid content); powdered herb in capsules
The green, branched vegetative stems are the official drug in the European Pharmacopoeia (Equiseti herba), German Commission E monograph, and EMA (European Medicines Agency) community herbal monograph. These sterile stems are the primary source of bioavailable silicic acid, flavonoids, and other therapeutic constituents. The fertile (spore-bearing) stems that appear in early spring are NOT used medicinally. The sterile stems are collected in summer when silica content is at its peak. The high silica content makes them extremely durable when dried and gives them their characteristic gritty, abrasive texture. They must be properly authenticated to exclude admixture with toxic Equisetum palustre.
Fresh juice (Succus Equiseti, Presssaft)
Preferred: Stabilized expressed fresh juice (Presssaft), taken diluted in water
Freshly pressed juice of the green aerial stems, stabilized for preservation. Schoenenberger Pflanzensaft (plant juice) is the best-known commercial preparation of this type, widely used in Germany and Central Europe. The fresh juice contains monosilicic acid (orthosilicic acid, Si(OH)4) in its most bioavailable water-soluble form. Fresh juice preparations may provide superior bioavailability of silicon compared to dried herb preparations, as some silicic acid polymerizes into less absorbable forms during drying. Used internally as a diuretic and connective tissue tonic, and externally as a wound wash.
Rhizome (root)
Preferred: Not routinely used; decoction if employed at all
The underground rhizome system has been used in some folk medicine traditions but is NOT the official pharmacopeial part. The rhizome is difficult to harvest due to its depth and extent, and its phytochemical profile differs from the aerial stems (lower silica content, different alkaloid profile). Not recommended for routine medicinal use. Some historical Eclectic medicine references mention the rhizome for urinary complaints, but modern practice focuses exclusively on the aerial stems.
Key Constituents
Silica and silicic acids (mineral constituents)
The silica/silicic acid content is the cornerstone of horsetail's therapeutic identity and the basis for its primary indication as a connective tissue tonic and remineralizing agent. Silicon is required for the cross-linking of collagen and elastin fibers, the synthesis of glycosaminoglycans (GAGs) in cartilage and synovial fluid, and the mineralization of bone matrix. Deficiency of dietary silicon has been associated with impaired bone and connective tissue formation in animal models (Carlisle 1972, 1982). The Framingham Offspring Study (Jugdaohsingh et al. 2004) found a positive association between dietary silicon intake and bone mineral density in premenopausal women and men. Horsetail provides silicon in a bioavailable organic matrix along with complementary minerals (potassium, calcium, magnesium), making it a unique whole-plant mineral supplement. The high potassium content also synergizes with the diuretic action, providing a naturally potassium-sparing aquaretic effect.
Flavonoids and flavonoid glycosides
The flavonoid fraction is pharmacologically important for its antioxidant, anti-inflammatory, diuretic, and capillary-stabilizing effects. Quercetin and its glycosides are among the best-characterized plant-derived anti-inflammatory agents, acting through multiple pathways (NF-kB inhibition, COX-2 suppression, mast cell stabilization). The flavonoids complement and synergize with the silica content: while silica provides structural mineral support for connective tissue, flavonoids protect that tissue from oxidative damage and inflammation. The European Pharmacopoeia uses total flavonoid content (minimum 0.3% as isoquercitroside) as the quality marker for Equisetum arvense, recognizing the importance of this constituent class for therapeutic activity.
Phenolic acids and hydroxycinnamic acid derivatives
The phenolic acid fraction contributes to the antioxidant, anti-inflammatory, and antimicrobial properties of horsetail. These compounds protect tissues from oxidative stress and may contribute to the wound-healing, diuretic, and urinary antiseptic properties traditionally attributed to the plant. Chlorogenic acid specifically may contribute to the mild hypoglycemic effects reported in some animal studies of horsetail extracts.
Alkaloids (trace levels in E. arvense)
The alkaloid content of properly authenticated E. arvense is toxicologically insignificant. The clinical importance of alkaloid analysis lies entirely in quality control: detection of palustrine alkaloids indicates contamination with the toxic species E. palustre and renders the material unsuitable for therapeutic use. Reputable suppliers test for palustrine contamination. Consumers and practitioners should purchase only from suppliers who can provide certificates of analysis demonstrating botanical authentication and absence of E. palustre alkaloids.
Organic acids
Organic acids contribute to the diuretic action of horsetail (urinary acidification promotes diuresis) and may enhance the bioavailability of mineral constituents by maintaining them in soluble, absorbable forms. The overall acid profile contributes to the mild astringent taste of horsetail preparations.
Phytosterols and steroids
The phytosterol fraction contributes modestly to the anti-inflammatory and connective tissue-supporting properties of horsetail. Beta-sitosterol's anti-inflammatory and urinary tract effects may complement the primary diuretic and remineralizing actions of the plant.
Saponins
Saponins are important contributors to the diuretic action of horsetail. They enhance renal blood flow and glomerular filtration, promoting increased urine volume and supporting the 'flushing therapy' for which horsetail is traditionally employed. Saponins may also enhance the absorption of other bioactive constituents, including silicic acid, from the gastrointestinal tract.
Enzymes
Thiaminase has no therapeutic value but is important for safety awareness and quality considerations. Its presence in raw plant material is the basis for the recommendation that horsetail should always be used in dried or heat-processed form rather than consumed raw. Heat processing (drying, infusion, decoction, extraction) effectively eliminates the thiaminase risk. This safety consideration has sometimes been overstated in popular sources, creating unnecessary alarm about a well-established and safely used medicinal plant when properly prepared.
Herbal Actions
Diuretic activity is the most extensively documented and widely recognized pharmacological action of Equisetum arvense. The diuretic effect is multifactorial: saponins (equisetonin) increase renal blood flow and glomerular filtration rate; flavonoids (quercetin and kaempferol glycosides) inhibit renal sodium reabsorption; and the high potassium content promotes osmotic diuresis. Importantly, horsetail acts as an 'aquaretic' — a term denoting promotion of water excretion without excessive electrolyte loss — rather than a potent saluretic diuretic like furosemide. The high potassium content of the plant partially compensates for urinary potassium losses, providing a naturally 'potassium-sparing' effect. This distinguishes horsetail from pharmaceutical loop and thiazide diuretics. Carneiro et al. (2014) demonstrated in a randomized, double-blind, controlled trial that E. arvense extract (900 mg/day) produced a diuretic effect comparable to hydrochlorothiazide (25 mg/day) without significant alteration of electrolyte balance. Commission E (Germany) and EMA (European Medicines Agency) both approve horsetail for 'flushing therapy' in urinary tract conditions, specifically for irrigation therapy in bacterial and inflammatory conditions of the lower urinary tract and for prevention of urinary gravel (calculi).
[1, 2, 6, 7]The connective tissue-supporting action of horsetail is attributed primarily to its exceptionally high silica content, providing bioavailable silicon (as monosilicic acid) essential for the structural integrity of collagen, elastin, glycosaminoglycans, and bone matrix. Silicon participates in collagen cross-linking (stabilizing the triple helix structure), promotes osteoblast differentiation and hydroxyapatite deposition in bone, and is concentrated in growing connective tissues including cartilage, tendons, arterial walls, skin dermis, hair cortex, and nail keratin. The Framingham Offspring Study (Jugdaohsingh et al. 2004) found that higher dietary silicon intake was significantly associated with greater bone mineral density at the hip in men and premenopausal women, independent of other mineral intake. Carlisle (1972, 1982) demonstrated that silicon is essential for normal connective tissue development in chick and rat models — silicon deprivation resulted in defective collagen formation, abnormal bone and cartilage architecture, and reduced glycosaminoglycan synthesis. Corletto (1999) reported improved bone mineral density in osteoporotic women supplemented with horsetail extract in a small pilot study. While the connective tissue-strengthening effects of horsetail-derived silicon are biologically plausible, well-supported by animal studies and epidemiological data, and consistent with extensive traditional use, large-scale confirmatory clinical trials in humans are still needed.
[8]Tightens and tones tissue, reduces secretions
Horsetail demonstrates moderate astringent activity attributable to its flavonoid content (quercetin and kaempferol glycosides), phenolic acids, and silica. The astringent action tones and tightens mucous membranes and damaged tissue, contributing to its traditional use for wound healing, hemorrhage control, and management of excessive mucosal discharges. Topically, horsetail preparations are astringent to skin and mucous membranes. Internally, the astringent action contributes to its efficacy in managing excessive urinary bleeding (hematuria) and as an adjunct in diarrheal conditions. The silica content itself has a physical astringent and tissue-strengthening quality.
[3, 4]Horsetail has been used since antiquity as a wound-healing agent, applied externally as a compress, wash, or poultice to cuts, abrasions, and chronic ulcers. The wound-healing activity is multifactorial: silicic acid promotes fibroblast proliferation and collagen synthesis, flavonoids reduce wound inflammation and oxidative damage, and the astringent action helps control bleeding. Carneiro et al. (2009) demonstrated in a rat wound model that topical application of E. arvense ointment significantly accelerated wound closure compared to controls, with enhanced collagen deposition, reduced inflammatory infiltrate, and improved tissue organization histologically. The traditional use of horsetail poultices for wound care is consistent with the modern understanding of silicon's role in connective tissue repair.
[4, 10]Horsetail has a long history of traditional use as a hemostatic agent to stop bleeding, both externally (nosebleeds, wound hemorrhage) and internally (hematuria, heavy menstruation, hemorrhoidal bleeding). The hemostatic action is attributed to the astringent flavonoids and phenolic compounds that constrict blood vessels and precipitate proteins at the wound surface, combined with the silica content that physically promotes clot formation. Dioscorides (1st century CE) and Pliny the Elder specifically recommended Equisetum for wound staunching. In modern herbal practice, horsetail is considered a mild hemostatic rather than a primary treatment for serious hemorrhage.
[3, 11]Reduces inflammation
The anti-inflammatory activity of horsetail is mediated primarily by its flavonoid constituents (quercetin, kaempferol, and their glycosides), which inhibit NF-kB, COX-2, and 5-lipoxygenase inflammatory pathways, stabilize mast cell membranes to reduce histamine release, and scavenge reactive oxygen species that perpetuate inflammation. Phenolic acids (caffeic acid, chlorogenic acid) contribute additional anti-inflammatory effects. Cetojevi-Simin et al. (2010) demonstrated significant antioxidant activity and reduction of oxidative stress markers with E. arvense extracts in vitro. The anti-inflammatory action supports the traditional use of horsetail for inflammatory urinary tract conditions, joint inflammation, and as a topical anti-inflammatory for skin conditions and wound healing.
[6]Prevents or slows oxidative damage to cells
Horsetail extracts demonstrate significant antioxidant activity in multiple in vitro assay systems, including DPPH radical scavenging, ABTS radical decolorization, ferric reducing antioxidant power (FRAP), and inhibition of lipid peroxidation. The antioxidant activity is attributed primarily to the flavonoid fraction (quercetin glycosides, kaempferol glycosides) and phenolic acids (caffeic acid, chlorogenic acid). Cetojevi-Simin et al. (2010) comprehensively characterized the antioxidant activity of E. arvense extracts and found potent free radical scavenging capacity. The antioxidant action contributes to tissue protection, supports wound healing, and may contribute to the connective tissue-preserving effects attributed to horsetail.
[]Kills or inhibits the growth of microorganisms
Mild antimicrobial activity has been demonstrated for horsetail extracts against various bacterial and fungal species in vitro. The antimicrobial constituents include phenolic acids, flavonoids, and saponins. While the antimicrobial activity is insufficient to qualify horsetail as a primary antimicrobial agent, it may contribute to the traditional use of horsetail in urinary tract infection management (in combination with the flushing/diuretic effect) and as an external wound wash. The antimicrobial action is best understood as supportive and synergistic with the primary diuretic and vulnerary actions rather than therapeutically primary.
[6]Therapeutic Indications
Urinary System
Urinary tract infections (UTI) — adjunctive flushing therapy
Commission E (Germany) and EMA (European Medicines Agency) approve horsetail for 'flushing therapy' (Durchspuelungstherapie) as an adjunct in bacterial and inflammatory conditions of the lower urinary tract. The therapeutic principle is irrigation: the increased urine volume produced by horsetail's diuretic action physically flushes bacteria and inflammatory debris from the urinary tract, reducing bacterial load and symptom duration. Adequate fluid intake (at least 2 liters of water daily) is essential alongside horsetail use for effective irrigation therapy. Horsetail is NOT a substitute for antibiotics in confirmed UTI but is used as a supportive measure alongside antimicrobial treatment, or for mild, early-stage uncomplicated UTI in otherwise healthy individuals. The mild antimicrobial and anti-inflammatory actions of horsetail flavonoids provide additional benefit beyond simple volume diuresis. This indication has a centuries-long traditional precedent and is supported by German Commission E approval (1988) and EMA traditional use registration.
[1, 2, 3]Edema (mild, non-cardiac, non-renal)
Horsetail's diuretic action is effective for mild edema of non-pathological origin (e.g., premenstrual fluid retention, mild gravitational edema). Carneiro et al. (2014) demonstrated that E. arvense extract produced diuretic effects comparable to hydrochlorothiazide without disturbing electrolyte balance. CRITICAL CONTRAINDICATION: Horsetail should NOT be used for edema caused by impaired cardiac function or impaired renal function, as the forced diuresis could worsen the underlying condition. Commission E explicitly contraindicated its use for edema resulting from cardiac or renal insufficiency.
[1, 7]Kidney stone (urolithiasis) prevention — traditional flushing therapy
Horsetail has a long tradition of use for preventing kidney stone formation, based on the principle that increased urine volume and flow rate reduces the supersaturation of stone-forming minerals (calcium oxalate, uric acid) in the urine, preventing crystal nucleation and growth. Commission E lists prevention of renal gravel as an approved indication. The diuretic flushing action is the primary mechanism. Note: the oxalic acid content of horsetail could theoretically increase calcium oxalate stone risk, creating a pharmacological paradox; however, the net effect of the diuretic flushing is believed to outweigh any contribution from oxalic acid at normal therapeutic doses. Patients with established kidney stones or recurrent stone formation should consult a physician before using horsetail.
[1, 3]Enuresis (bedwetting) in children — traditional use
Paradoxically, despite its diuretic action, horsetail has a traditional reputation for treating enuresis (bedwetting) in children. The theoretical basis for this seemingly contradictory use is the astringent, tissue-toning action of silica and flavonoids on the bladder musculature and urinary sphincter, improving bladder tone and sphincter control. In this application, horsetail is typically given during the daytime (NOT before bed) to strengthen bladder tissues over time, with the diuretic effect occurring during waking hours. This is a purely traditional indication without clinical trial support, used in the context of Eclectic and European folk medicine.
[4, 5]Hematuria (blood in urine) — traditional hemostatic use
Traditional use for mild hematuria, based on the astringent and hemostatic properties of horsetail. Used in Eclectic medicine for hematuria associated with urinary tract inflammation. This is a symptom-level treatment; hematuria always requires medical investigation to exclude serious underlying causes (malignancy, glomerulonephritis, etc.) before any herbal treatment is considered.
[4, 5]Musculoskeletal System
Osteoporosis support and bone mineral density maintenance
Horsetail is widely used in complementary practice as a supportive agent for bone health and osteoporosis prevention, based on the silicon-collagen-bone mineralization axis. Silicon is essential for the cross-linking of collagen fibers that form the organic matrix of bone, and for the deposition of calcium hydroxyapatite crystals onto that matrix. The Framingham Offspring Study (Jugdaohsingh et al. 2004) demonstrated a statistically significant positive association between dietary silicon intake and bone mineral density (BMD) at the hip in men and premenopausal women. Corletto (1999) conducted a pilot study in osteoporotic women using E. arvense extract supplementation and reported improvements in bone mineral density as measured by DEXA scanning, though the study had methodological limitations (small sample size, limited controls). Spector et al. (2008) found that dietary silicon intake was positively associated with cortical bone mineral density in the TWINS UK cohort. While these data are promising and biologically plausible, large-scale, well-controlled clinical trials specifically evaluating horsetail supplementation for osteoporosis are still needed.
[8]Fracture healing support
Traditional use of horsetail to support bone fracture healing, based on the silicon requirement for new bone formation. Silicon is concentrated at the mineralization front of growing bone and is required for osteoblast differentiation and activity. Animal studies have demonstrated that silicon supplementation accelerates fracture callus formation and mineralization. In traditional European herbal practice and Eclectic medicine, horsetail was recommended during fracture recovery to support bone knitting. This remains a plausible but unproven indication in humans — no clinical trials have specifically studied horsetail for fracture healing.
[4]Joint health, cartilage support, and osteoarthritis adjunct
Silicon is essential for the synthesis of glycosaminoglycans (GAGs, including chondroitin sulfate and hyaluronic acid) that are the primary structural components of articular cartilage and synovial fluid. Silicon deprivation in animal models results in defective cartilage formation with reduced GAG content. Horsetail's silicon content, combined with the anti-inflammatory flavonoids (quercetin, kaempferol), provides a rational basis for its traditional use in supporting joint health. Some practitioners recommend horsetail as an adjunct for osteoarthritis management, though direct clinical trial evidence for this indication is lacking.
[4]Connective tissue repair and strengthening (general)
Broad traditional use for strengthening all connective tissues — tendons, ligaments, fascia, arterial walls, and intervertebral discs. Silicon is a required cofactor for prolyl hydroxylase, the enzyme that hydroxylates proline residues in procollagen, a step essential for stable collagen triple helix formation. Horsetail is thus considered a general connective tissue tonic, used for conditions involving connective tissue weakness or degeneration, including hernias, varicose veins, and post-surgical connective tissue repair.
[4]Skin / Integumentary
Hair strengthening and hair loss (supportive)
Horsetail is widely used in complementary dermatological practice and in commercial hair care products for hair strengthening and hair loss support. Silicon is concentrated in the hair cortex and is essential for the structural integrity of hair keratin. Sandhu et al. (2010) studied the effects of an E. arvense-derived silicon supplement on hair morphology and tensile strength and reported improvements in hair thickness, shine, and reduced breakage compared to placebo over a 9-month supplementation period. The study was small but represents one of the few direct clinical evaluations of horsetail for this popular indication. Horsetail is a common ingredient in European natural hair care formulations, both as an oral supplement and in topical shampoos and rinses.
[9]Nail strengthening (brittle nails, onychoschizia)
Silicon is a component of the nail matrix and contributes to nail hardness and structural integrity. Supplementation with bioavailable silicon has been reported to improve nail brittleness and splitting in anecdotal reports and case series, though controlled clinical trials specific to horsetail for nail health are limited. The indication is biologically plausible and consistent with the biochemistry of silicon in keratinized tissues. Horsetail is commonly recommended by naturopathic practitioners for brittle, splitting, or slow-growing nails.
[4]Skin health, wound healing, and dermatological conditions
Silicon is concentrated in the dermis and is essential for the structural integrity of dermal collagen and elastin. Horsetail has been used traditionally both internally (as a connective tissue tonic for skin health) and externally (as a wash or compress for wounds, eczema, and inflammatory skin conditions). Carneiro et al. (2009) demonstrated accelerated wound healing with topical E. arvense ointment in a rat model, with enhanced collagen deposition and reduced inflammation. The vulnerary and anti-inflammatory properties support topical use for minor wounds, mild eczema, and skin irritation. Some anti-aging skincare formulations include horsetail extract for its silicon-mediated collagen support.
[9, 10]Respiratory System
Upper respiratory catarrh (excess mucus production)
Traditional European herbal medicine use for upper respiratory catarrh and nasal congestion, based on the astringent and drying action of horsetail on mucous membranes. The cool, dry energetic quality makes horsetail appropriate for conditions with excessive mucus production (damp tissue state). Used as an infusion or as part of a formula with other respiratory herbs (e.g., elderflower, eyebright, ground ivy). This is a traditional indication without specific clinical trial support for the respiratory application.
[3, 4]Cardiovascular System
Atherosclerosis and vascular health support (traditional)
Silicon is concentrated in the walls of the aorta and major arteries, where it contributes to the structural integrity of arterial elastic tissue. Epidemiological studies have found an inverse correlation between silicon intake and atherosclerosis risk. Loeper et al. (1979) found that silicon content of the aortic wall decreases with advancing atherosclerosis, and that silicon supplementation reduced experimental atherosclerosis in rabbit models. Horsetail has been used traditionally by some European herbalists as a long-term tonic for vascular health, based on silicon's role in maintaining arterial wall elasticity. This indication remains speculative and has not been validated in human clinical trials.
[4]Immune System
Immune support (minor, as part of urinary tract infection management)
While horsetail is not a primary immune-stimulating herb, its use in managing urinary tract infections involves a secondary immune-supportive component: the flushing action reduces bacterial load, allowing the body's innate immune defenses to overcome the infection more effectively. The antioxidant and anti-inflammatory flavonoids may also support local mucosal immunity. Horsetail is best understood as supporting immune function indirectly through its diuretic and anti-inflammatory actions rather than as a direct immunostimulant.
[3]Energetics
Temperature
cool
Moisture
dry
Taste
Tissue States
damp/relaxation, damp/stagnation, heat/excitation
In Western herbal energetics, horsetail is classified as cool and dry, reflecting its astringent, diuretic, and tissue-tightening qualities. The cooling and drying nature makes it particularly suited for conditions characterized by excess dampness, tissue laxity, and mild inflammation — precisely the tissue states seen in urinary tract infections (damp/heat), edema (damp/stagnation), and connective tissue weakness with poor tone (damp/relaxation). The bland taste reflects its high mineral and silica content (minerally, earthy flavor), while the mild bitterness indicates the phenolic acid and saponin content. The slight sweetness is characteristic of a mild tonic quality. Horsetail is considered a tissue-tightening and remineralizing remedy — it 'firms up' lax, boggy, over-relaxed tissues and provides structural mineral support. In traditional Chinese medicine, E. arvense is not extensively used (E. hyemale / Mu Zei is the Chinese pharmacopeial Equisetum species), but where it appears, it is classified as sweet, bitter, and neutral to slightly cool, entering the Lung and Liver channels, with functions of clearing wind-heat from the eyes, stopping bleeding, and promoting urination. In Ayurveda, horsetail has limited traditional use but would be classified as having a kashaya (astringent) and tikta (bitter) rasa, with a cooling virya, appropriate for reducing excess Kapha and Pitta. CAVEAT: Herbal energetics are interpretive frameworks within Western herbalism and various traditional medicine systems, not standardized across all practitioners.
Traditional Uses
Classical Greek and Roman medicine (Dioscorides, Pliny the Elder, Galen)
- Wound staunching and hemorrhage control — applied as a poultice or compress to bleeding wounds
- Treatment of dysentery and intestinal bleeding
- Diuretic for dropsy (edema) and urinary complaints
- Stopping nosebleeds (epistaxis) — fresh juice applied intranasally or powdered herb inhaled
- Treatment of cough and respiratory complaints
- Applied externally to ulcers, fistulae, and slow-healing wounds
"Dioscorides (De Materia Medica, 1st century CE) described Hippuris (Equisetum) as having 'a binding and drying quality' and recommended it for wound staunching: 'The juice of it drunk is good for dysentery... it stops bleeding from the nostrils being applied, and is good for wounds.' Pliny the Elder (Naturalis Historia, 1st century CE) wrote that horsetail 'has such astringent properties that it will even stanch the blood of wounds' and noted its use for coughs, urinary complaints, and intestinal disorders. Galen classified Equisetum among the strongly drying and moderately cooling remedies."
Medieval European herbal medicine (Hildegard von Bingen, medieval herbals)
- Treatment of wounds, ulcers, and hemorrhage (continuation of classical use)
- Internal use for bladder and kidney complaints, including kidney stones and painful urination
- Tuberculosis and lung complaints (folk use)
- Scouring and polishing metal, wood, and pewter — the high silica content made horsetail an essential household and workshop item before the availability of modern abrasives
"Throughout the medieval period, horsetail served dual roles as both medicine and practical household tool. Its extreme abrasiveness (due to silica content) made it the standard material for polishing metal, scouring pots and pans, and finishing woodwork — giving rise to common names 'scouring rush' and 'pewterwort.' Hildegard von Bingen (12th century) described its use for tumors and wounds. The practical and medicinal uses were closely intertwined: the same silica that made it useful for scouring was recognized as responsible for its tissue-strengthening medicinal properties. Pewter workers used it extensively, hence the name 'pewterwort' in English herbals."
Native American traditional medicine
- Kidney and urinary tract conditions — used by multiple Nations as a diuretic tea
- Stopping bleeding from wounds and hemorrhage
- Treatment of coughs, colds, and respiratory infections
- Bone-setting support — horsetail preparations used alongside splinting of fractures
- Gastrointestinal complaints including diarrhea and stomach pain
- External wash for sores, skin irritation, and rashes
- Dental abrasive — used to clean and polish teeth due to silica content
"Multiple Native American Nations utilized Equisetum species medicinally. The Okanagan-Colville used E. arvense tea as a kidney remedy. The Blackfoot used it for urinary tract conditions and as a general tonic. The Cheyenne used horsetail tea for coughs and kidney problems. The Potawatomi used it as a diuretic. Several Nations recognized its wound-healing and bleeding-stopping properties, paralleling classical European use. The use of horsetail for tooth cleaning and polishing (leveraging the natural abrasive silica) is a fascinating parallel to its European use as a scouring agent. (Note: specific tribal attributions from ethnobotanical literature including Moerman 1998.)"
[13]
Eclectic medicine (American, 19th-20th century)
- Urinary complaints: cystitis, urethritis, hematuria, dysuria, enuresis (bedwetting)
- Dropsy (edema) as a diuretic
- Hemorrhage of various types: hematuria, menorrhagia (heavy menstrual bleeding), hemoptysis
- Vesical irritation with frequent and painful urination
- Prostatic enlargement with urinary difficulty
- Kidney and bladder gravel (calculi)
- Chronic pulmonary conditions with hemorrhage
"King's American Dispensatory (Felter & Lloyd, 1898) described Equisetum as follows: 'This plant is diuretic, and is useful in dropsy, gravel, and vesical diseases generally. It is likewise of some value in gonorrhea, gleet, and the excessive secretion of mucus from the bladder and urethra. Combined with hydrangea root, it has been favorably reported upon as a remedy in prostatic enlargement. The decoction has been used for the suppression of urine in infants. Large doses produce effects similar to those of ergot.' The Eclectic physicians valued horsetail primarily as a urinary tract remedy, considering it among the most reliable plant-based diuretics. Harvey Wickes Felter (Eclectic Materia Medica, 1922) emphasized its hemostatic properties for urinary hemorrhage."
[5]
German and Central European phytotherapy (Commission E tradition, Weiss, Madaus)
- Flushing therapy (Durchspuelungstherapie) for urinary tract infections and inflammation
- Prevention of renal gravel (kidney stone prevention)
- Post-traumatic and static edema (mild fluid retention)
- External application: poorly healing wounds, ulcers
- Connective tissue strengthening and remineralization
- Supportive treatment for osteoporosis and bone health
- Hair and nail strengthening (Schoenenberger fresh plant juice)
"The German Commission E monograph (1988) approved Equisetum arvense for internal use as 'flushing therapy in bacterial and inflammatory diseases of the lower urinary tract, renal gravel; post-traumatic and static edema' and for external use for 'supportive treatment of poorly healing wounds.' Rudolf Fritz Weiss (Herbal Medicine, 1988/2001) considered horsetail primarily as a diuretic and connective tissue remedy, emphasizing the importance of its silicic acid content for bone, cartilage, and connective tissue health. The Schoenenberger fresh plant juice (Presssaft) is a widely used German preparation of horsetail particularly valued for its bioavailable monosilicic acid content. Sebastian Kneipp (19th century) recommended horsetail baths for rheumatic conditions and circulatory support."
Anthroposophic medicine (Rudolf Steiner tradition)
- Kidney and urinary tract support — considered a specific remedy for the kidney organ system
- Connective tissue and 'formative forces' support
- Equisetum baths (Sitz baths) for urinary tract inflammation and enuresis
- Horsetail as a biodynamic agricultural spray (preparation 508) for fungal disease prevention
"In anthroposophic medicine (derived from the insights of Rudolf Steiner and developed by Ita Wegman), horsetail holds a special place as a plant that embodies strong 'silica forces' — representing the light, form-giving, structuring principle in nature. The pronounced silica metabolism of Equisetum is seen as a signature of its affinity for the kidney-urinary system and for connective tissue processes that give form and structure to the body. Equisetum preparations are used anthroposophically for kidney support, enuresis, and connective tissue weakness. In biodynamic agriculture, horsetail tea (preparation 508) is sprayed on crops to prevent fungal diseases, a practical application of its antifungal silica content."
[4]
Modern Research
Diuretic effect of Equisetum arvense compared to hydrochlorothiazide (clinical trial)
Randomized, double-blind, controlled clinical trial comparing the diuretic effect and electrolyte safety of E. arvense dry extract (900 mg/day) versus hydrochlorothiazide (25 mg/day) versus placebo in 36 healthy male volunteers over 4 days.
Findings: E. arvense extract produced a diuretic effect comparable to hydrochlorothiazide, with significantly increased 24-hour urine volume compared to placebo (P < 0.01). Critically, unlike hydrochlorothiazide, the horsetail extract did not cause significant alteration of sodium or potassium excretion ratios, demonstrating a more favorable electrolyte profile. The diuretic onset was observed within the first 24 hours and was maintained throughout the 4-day study period. No significant adverse effects were reported in either active treatment group. The authors concluded that E. arvense extract demonstrates clinically relevant diuretic activity with a potentially superior safety profile compared to conventional thiazide diuretics with respect to electrolyte disturbance.
Limitations: Small sample size (n=36). Short duration (4 days). Healthy male volunteers only — results may not generalize to patients with urinary tract conditions or edema. Single commercial extract tested. No long-term follow-up data.
[7]
Bone mineral density effects of Equisetum arvense supplementation (pilot study)
Pilot clinical study evaluating the effect of E. arvense extract supplementation on bone mineral density (BMD) in postmenopausal women with osteopenia or osteoporosis.
Findings: Women supplemented with E. arvense extract showed improvements in bone mineral density at the lumbar spine and femoral neck as measured by DEXA scanning compared to baseline values. The improvements were attributed to the bioavailable silicon content supporting collagen cross-linking and hydroxyapatite deposition in bone matrix. The study provided preliminary evidence that horsetail-derived silicon supplementation may have a positive effect on bone metabolism in postmenopausal women at risk for osteoporosis.
Limitations: Small pilot study with significant methodological limitations: limited sample size, lack of robust placebo control, relatively short observation period, and potential confounding variables (diet, physical activity, concurrent calcium/vitamin D supplementation). While the results are promising and biologically plausible, larger randomized controlled trials are needed to confirm these preliminary findings.
[8]
Diuretic activity of Equisetum arvense — pharmacological review
Comprehensive pharmacological review of the diuretic, antioxidant, anti-inflammatory, and other biological activities of Equisetum arvense, integrating in vitro, in vivo, and clinical data.
Findings: Confirmed the diuretic activity of E. arvense through multiple mechanisms: saponin-mediated increase in renal blood flow and glomerular filtration, flavonoid inhibition of sodium reabsorption, and osmotic effects of the high potassium content. The review also documented antioxidant activity (free radical scavenging by flavonoids and phenolic acids), anti-inflammatory effects (NF-kB and COX-2 inhibition by quercetin and kaempferol glycosides), antimicrobial activity against urinary pathogens, and hepatoprotective effects in animal models. The safety profile was confirmed as favorable with appropriate use, with emphasis on the importance of species authentication to exclude E. palustre contamination.
Limitations: Narrative review, not a systematic review with formal quality assessment. The heterogeneity of horsetail preparations across studies makes direct comparison difficult. Many cited studies used animal models, with limited clinical trial data available.
[6]
Antioxidant activity and cytotoxicity assessment of Equisetum arvense extracts
In vitro study comprehensively evaluating the antioxidant capacity, phenolic content, flavonoid profile, and cytotoxic effects of various E. arvense extracts (aqueous, ethanolic, methanolic).
Findings: E. arvense extracts demonstrated potent antioxidant activity across multiple assay systems: DPPH radical scavenging (IC50 values in the range of 50-200 microg/mL depending on extract type), ABTS radical decolorization, reducing power, and inhibition of lipid peroxidation. The ethanolic and methanolic extracts showed greater antioxidant activity than aqueous extracts, reflecting higher extraction efficiency for flavonoids and phenolic acids. The extracts showed selective cytotoxicity against certain tumor cell lines (including colon carcinoma HT-29 and breast carcinoma MCF-7 cells) while being relatively non-toxic to normal cells. The antioxidant activity correlated strongly with total phenolic and flavonoid content, particularly quercetin and kaempferol glycosides.
Limitations: In vitro study — results cannot be directly extrapolated to in vivo efficacy. The concentrations used in cell culture experiments may not be achievable through oral consumption. Cytotoxicity data is preliminary and does not suggest clinical anticancer application.
[]
Effects of silicon supplementation on hair morphology and tensile strength
Clinical study evaluating the effects of an orthosilicic acid-rich supplement derived from Equisetum arvense on hair quality parameters including thickness, tensile strength, and overall appearance over a 9-month supplementation period.
Findings: Participants receiving the silicon supplement showed significant improvements in hair tensile strength (break load increased), hair thickness (cross-sectional area), and subjective assessment of hair quality (shine, texture, manageability) compared to the placebo group after 9 months of supplementation. The improvements were attributed to enhanced keratin synthesis and structural stabilization mediated by increased silicon availability for cross-linking reactions. These findings support the traditional use of horsetail for hair strengthening and provide one of the few controlled clinical evaluations of silicon supplementation for cosmetic dermatological outcomes.
Limitations: Relatively small sample size. Subjective outcome measures (hair appearance assessment) alongside objective measures (tensile strength). Single commercial preparation — results may not generalize to all horsetail products. 9-month duration may not capture the full time course of effects on hair growth cycle (anagen phase is 2-6 years).
[9]
Wound healing activity of Equisetum arvense ointment (animal model)
Preclinical study evaluating the wound-healing effects of topically applied E. arvense extract ointment in a standardized excisional wound model in rats.
Findings: Topical application of E. arvense ointment (5% and 10% concentrations) significantly accelerated wound closure compared to vehicle control and untreated wounds. Histological analysis revealed enhanced collagen deposition (measured by Masson's trichrome staining), increased fibroblast proliferation, reduced inflammatory cell infiltrate, and improved tissue organization and re-epithelialization in treated wounds. The 10% ointment showed a dose-dependent improvement over the 5% formulation. The wound-healing activity was attributed to the combined effects of silicic acid (promoting collagen synthesis), flavonoids (reducing inflammation and oxidative damage), and astringent phenolic compounds (promoting tissue contraction).
Limitations: Animal model study — wound healing in rats differs from human wound healing in important ways (contraction vs. re-epithelialization, different immune response). Topical application; internal bioavailability not assessed. Specific extract preparation; results may vary with different extraction methods. No human clinical trials specifically for wound healing have been conducted.
[10]
Dietary silicon intake and bone mineral density — epidemiological evidence (Framingham Offspring Study)
Cross-sectional analysis of the association between dietary silicon intake and bone mineral density (BMD) in the Framingham Offspring Study cohort (n=2847), a major long-running epidemiological study.
Findings: Higher dietary silicon intake was significantly and positively associated with bone mineral density at the femoral trochanter and Ward's triangle in men and premenopausal women (P < 0.005). The effect was independent of age, BMI, smoking, alcohol intake, physical activity, estrogen use, calcium intake, and vitamin D intake. The magnitude of the silicon-BMD association was comparable to that of calcium. In postmenopausal women, the association was attenuated and not statistically significant, possibly reflecting the dominant influence of estrogen withdrawal on postmenopausal bone loss. The study provided the first large-scale epidemiological evidence linking dietary silicon intake to bone health in humans, supporting the animal and mechanistic data from Carlisle and others.
Limitations: Cross-sectional (not longitudinal) design cannot establish causation. Dietary silicon intake was estimated from food frequency questionnaires, which may have measurement error. The food-based silicon sources differed from supplemental silicon sources like horsetail. Results cannot directly demonstrate that horsetail supplementation specifically would improve BMD. Postmenopausal women (the population most at risk for osteoporosis) did not show significant associations, possibly due to confounding by hormone status.
[]
EMA assessment report on Equisetum arvense (community herbal monograph)
European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) comprehensive assessment of E. arvense, including traditional use evidence, pharmacological data, and safety evaluation for registration as a traditional herbal medicinal product.
Findings: The EMA assessment confirmed the traditional use of E. arvense for two registered indications: (1) 'To increase the amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints' (traditional use registration), and (2) 'Traditional herbal medicinal product for the treatment of minor wounds' (traditional use, external application). The assessment reviewed the phytochemical profile (silicic acid, flavonoids, phenolic acids), pharmacological data (diuretic, antioxidant, anti-inflammatory, wound healing), and safety data (favorable safety profile with proper species authentication, thiaminase inactivation by processing, contraindication in cardiac/renal edema). The HMPC concluded that plausible efficacy was established based on longstanding traditional use and supportive pharmacological data, though clinical trial evidence remained limited.
Limitations: Regulatory assessment document, not a systematic review. Traditional use registration is based on historical evidence of safety and plausible efficacy, NOT on clinical trial proof of efficacy. The EMA explicitly noted the need for further clinical studies to confirm the traditional indications.
[2]
Preparations & Dosage
Infusion (Tea)
Strength: 2-4 g dried herb per 250 mL water. European Pharmacopoeia: minimum 0.3% total flavonoids (as isoquercitroside).
Place 2-4 g (1-2 teaspoons) of dried, cut Equisetum arvense herb in a cup or teapot. Pour 250 mL (1 cup) of freshly boiled water over the herb. Cover and steep for 10-15 minutes (longer steeping improves silica extraction). Strain and drink. For enhanced silica extraction, some practitioners recommend a brief simmer (5-10 minutes) before the steeping period, effectively making a light decoction. The resulting tea is pale greenish-yellow, mildly earthy and mineral-tasting, with a subtle astringent quality and a faintly grassy aroma. The taste is mild and generally well-tolerated. Adequate additional water intake (at least 1.5-2 liters daily) should accompany use when employed as a diuretic flushing therapy.
2-4 g dried herb per cup, 3-4 cups daily. Commission E: 6 g daily of the drug for internal use. EMA: 2-4 g per cup, up to 4 times daily.
Three to four times daily between meals
For flushing therapy: 2-4 weeks as acute treatment for urinary complaints. For connective tissue/bone support: may be used long-term (3-6 months) with periodic breaks (e.g., 5 days on, 2 days off, or 3 weeks on, 1 week off). Reassess therapeutic need periodically.
Not well-established for children under 12. Adolescents 12-17: half adult dose (1-2 g per cup, 2-3 times daily) under practitioner guidance.
Infusion is the most commonly used and accessible preparation. It efficiently extracts flavonoids, phenolic acids, and water-soluble minerals (potassium, calcium, magnesium). Monosilicic acid (the bioavailable form of silicon) is water-soluble and partially extracted by infusion, though decoction or fresh juice preparations may provide greater silicic acid yields. The silica content also makes the herb somewhat resistant to complete extraction — longer steeping and hotter water improve yields. For flushing therapy, adequate concurrent water intake is essential to achieve the desired irrigation effect. The infusion may be combined with other urinary tract herbs such as goldenrod (Solidago), birch leaf (Betula), bearberry (Arctostaphylos uva-ursi), or corn silk (Zea mays) for enhanced synergistic effect.
Decoction
Strength: 4-6 g dried herb per 500 mL water; traditional decoction ratio approximately 1:80-1:125
Place 4-6 g (2-3 teaspoons) of dried, cut Equisetum arvense herb in a saucepan with 500 mL (2 cups) of cold water. Bring to a gentle boil, then reduce heat and simmer for 15-20 minutes with the lid on. Remove from heat and allow to steep for an additional 10 minutes. Strain. The longer simmer time compared to a standard infusion is recommended because the dense, silica-rich cell walls of horsetail require more vigorous extraction to release their mineral and silicic acid content. The resulting decoction is a darker greenish-yellow to amber, with a more pronounced mineral-earthy taste than the infusion.
4-6 g dried herb per 500 mL. Drink throughout the day in 3-4 divided portions.
Prepare once daily; divide into 3-4 portions consumed throughout the day.
Same as infusion guidelines.
Not well-established. Adolescents: half adult dose under practitioner guidance.
Decoction is preferred over simple infusion when maximum silica extraction is desired, particularly for connective tissue, bone, and hair/nail/skin indications where silicon availability is the primary therapeutic goal. The prolonged simmering helps convert polymerized silica to more bioavailable monosilicic acid and disrupts the resistant cell walls. Some traditional herbalists recommend adding a small amount of sugar or honey to the decoction, as sugar may enhance the solubility of silicic acid. An alternative technique involves a 2-hour cold maceration followed by a 20-minute simmer, which some practitioners believe maximizes extraction of both water-soluble and heat-released constituents.
Tincture
Strength: 1:5, 25-45% ethanol (dried herb).
Use dried, cut Equisetum arvense herb. Standard maceration: 1:5 ratio in 25-45% ethanol (lower alcohol concentration than many herbal tinctures is acceptable because the primary active constituents — silicic acid, flavonoids, and minerals — are water-soluble or moderately polar). Macerate for 2-4 weeks with daily agitation. Press and filter. Some manufacturers use a percolation method for commercial tincture production.
2-6 mL (40-120 drops) three times daily
Three times daily, taken in a small amount of water
May be used for 2-4 weeks for acute urinary conditions, or longer-term for connective tissue support.
Not recommended for children due to alcohol content. Glycerite alternative may be used (see notes).
Tincture is a convenient dosage form but may not be the optimal preparation for maximizing silicic acid delivery, as the bioavailable monosilicic acid is best extracted by water. The tincture does efficiently extract flavonoids, phenolic acids, saponins, and phytosterols. For indications primarily requiring silica (bone, connective tissue, hair/nail support), infusion, decoction, or fresh juice may be more appropriate than tincture. For primarily diuretic indications, the tincture is adequate as the flavonoid and saponin content is well-extracted. A glycerite (1:5 in vegetable glycerin) can be prepared as an alcohol-free alternative suitable for children over 4 years and individuals avoiding alcohol.
[3]
fresh-plant-juice
Strength: Fresh plant juice (approximately 1:1), stabilized with ethanol or by pasteurization.
The fresh green sterile stems are collected during summer, washed, and immediately pressed to extract the juice using a commercial plant press or masticating juicer. The fresh juice is stabilized by the addition of a small amount of ethanol (approximately 20% by volume) or by flash pasteurization. The Schoenenberger Pflanzenpresssaft (plant press juice) is the best-known commercial preparation of this type, widely available in Germany, Austria, and Switzerland.
10-15 mL fresh juice diluted in water, two to three times daily. Schoenenberger commercial juice: 10 mL two to three times daily.
Two to three times daily
May be used for 4-6 weeks. Extended use possible under practitioner guidance.
Not well-established. Adolescents: half adult dose.
Fresh plant juice is considered by many European phytotherapists to be the SUPERIOR preparation for maximizing bioavailable monosilicic acid (orthosilicic acid) content, because the silicon in fresh plant tissue exists predominantly in the water-soluble monomeric form that is directly absorbable from the gastrointestinal tract. During drying, a proportion of monosilicic acid polymerizes into oligomeric and polymeric forms that are larger, less water-soluble, and less bioavailable. The fresh juice preserves the silicon in its most bioavailable state. The Schoenenberger brand Presssaft is the most widely studied and recommended commercial fresh juice product in German phytotherapy. This preparation is particularly recommended for connective tissue, bone, hair, nail, and skin indications where optimal silicon bioavailability is most important.
Capsule / Powder
Strength: Crude powder: 500 mg per capsule. Standardized extract: varies by manufacturer, typically 4:1 to 10:1 concentration, standardized to 5-10% silicic acid or equivalent silicon content.
Dried, finely powdered Equisetum arvense herb filled into vegetarian or gelatin capsules. Alternatively, standardized dry extract (typically standardized to silicic acid content or total flavonoid content) encapsulated. Products should specify silicic acid or silicon content per capsule for dosing guidance.
Crude powder: 1-3 g daily (2-6 capsules of 500 mg) in divided doses. Standardized extract: dosage varies by product concentration and standardization; follow manufacturer guidelines or practitioner recommendation. Products standardized to 7-10% silica: 250-500 mg extract, 2-3 times daily.
Two to three times daily with water, taken with meals
May be used long-term for connective tissue and bone support (3-6 months with periodic assessment). For diuretic indications: 2-4 weeks.
Not well-established for children. Adolescents: half adult dose under practitioner supervision.
Capsules are convenient but bioavailability of silica from crude dried powder may be limited compared to preparations that involve water extraction (infusion, decoction, fresh juice). This is because the silica in intact, dried plant cells may not be fully released during digestion. Extracted and standardized products that have undergone water or hydroalcoholic extraction are preferred for therapeutic use over crude powder capsules, as the extraction process disrupts cell walls and converts some polymerized silica to more bioavailable forms. Products should clearly state whether they contain crude powder or extract, and what the silica/silicon content per dose is. Third-party testing for botanical identity (confirming E. arvense and absence of E. palustre) and heavy metal content (particularly aluminum) is recommended.
external-compress
Strength: 10-15 g dried herb per liter of water (strong decoction for external use)
Prepare a strong decoction: simmer 10-15 g of dried Equisetum arvense herb in 1 liter of water for 30 minutes. Strain and allow to cool to a comfortable temperature. Soak a clean cloth or gauze in the warm decoction, wring out excess liquid, and apply to the affected area. Cover with a dry cloth or bandage to retain warmth and moisture. Leave in place for 15-30 minutes. Reapply 2-3 times daily.
10-15 g dried herb per liter of water for external compress. Apply 2-3 times daily.
Two to three times daily
Continue until wound healing is well established or condition resolves. For chronic conditions: ongoing as needed.
Same concentration; appropriate for children with parental supervision. Ensure temperature is safe before application.
External compresses are the primary preparation method for Commission E's approved external indication (supportive treatment of poorly healing wounds). The silicic acid, flavonoids, and phenolic acids in the decoction provide anti-inflammatory, antioxidant, and tissue-regenerating effects directly to the wound or affected skin. Horsetail compresses have been used traditionally for poorly healing wounds, leg ulcers, eczema, skin irritation, hemorrhoids, and minor burns. The compress can also be used as a sitz bath preparation (add 100 g dried herb to a full bath or proportionally less for a sitz bath) for hemorrhoidal or urogenital complaints. For foot baths: add 50 g dried herb to a foot bath and soak for 15-20 minutes.
Standardized Extract
Strength: Varies by manufacturer. Common DER 4:1 to 10:1. Standardized to 5-10% silicon (as silicic acid) and/or minimum 0.3% total flavonoids.
Commercially prepared standardized extracts, typically aqueous or hydroalcoholic, standardized to silicon/silicic acid content (commonly 5-10% silicon) and/or total flavonoid content (minimum 0.3% as per European Pharmacopoeia). These extracts undergo controlled extraction to optimize bioactive constituent yield and are available as dry extract powders (for encapsulation), liquid extracts, and concentrated drops.
Extract standardized to 7% silicon: 300-500 mg two to three times daily. Specific clinical trial dosages: Carneiro et al. (2014) used 900 mg/day of dry extract. Follow manufacturer guidelines or practitioner recommendation for specific products.
Two to three times daily
For diuretic indications: 2-4 weeks. For connective tissue/bone support: 3-6 months with periodic reassessment.
Not established in standardized extract form for children under 12.
Standardized extracts provide the most reproducible dosing and are the form used in clinical trials (e.g., Carneiro et al. 2014 diuretic study). Products should specify whether standardization is to silicon/silicic acid content, total flavonoid content, or both. Silicon standardization is particularly important for connective tissue and bone health indications. The extraction process may improve bioavailability compared to crude powdered herb by disrupting cell walls and converting polymerized silica to bioavailable monosilicic acid. Quality products should also certify botanical identity (E. arvense, free of E. palustre contamination) and test for heavy metals (aluminum, lead, cadmium).
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Commission E explicitly contraindicated horsetail for edema resulting from impaired heart function. Forced diuresis in cardiac edema can worsen hemodynamic instability, deplete intravascular volume, exacerbate electrolyte imbalances, and worsen cardiac output. Cardiac edema requires treatment directed at the underlying cardiac dysfunction, not empiric diuresis with herbal agents.
Commission E explicitly contraindicated horsetail for edema resulting from impaired kidney function. Forcing diuresis through already-compromised kidneys can worsen renal function, exacerbate electrolyte and fluid balance abnormalities, and is contraindicated on basic pharmacological grounds. Renal edema requires nephrology-directed management.
Although allergic reactions to horsetail are rare, individuals with known hypersensitivity should not use the plant in any form. Cross-reactivity between Equisetum species has not been well characterized but should be assumed possible.
Horsetail products contaminated with or substituted by Equisetum palustre (marsh horsetail) are UNSAFE due to the presence of the neurotoxic alkaloid palustrine and higher thiaminase content. Any product that cannot be authenticated as pure E. arvense should not be used. This is the single most important safety consideration for horsetail use. Products should be sourced from reputable suppliers who provide certificates of analysis confirming botanical identity.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Lithium (lithium carbonate, lithium citrate) (Mood stabilizers) | moderate | Horsetail's diuretic action promotes renal water and sodium excretion. Lithium reabsorption in the proximal tubule is closely linked to sodium reabsorption. Diuretic-induced sodium depletion can increase proximal tubular lithium reabsorption, raising serum lithium levels to potentially toxic concentrations. This mechanism is well-established for pharmaceutical diuretics (especially thiazides) and is pharmacologically plausible for herbal diuretics with significant activity. |
| Thiazide diuretics (hydrochlorothiazide, chlorthalidone), loop diuretics (furosemide, bumetanide), potassium-sparing diuretics (spironolactone, amiloride) (Diuretics) | moderate | Additive diuretic effect. Combining herbal diuretics with pharmaceutical diuretics could lead to excessive fluid loss, dehydration, and electrolyte imbalance (hyponatremia, hypokalemia, or in the case of potassium-sparing diuretics combined with high-potassium horsetail, potential hyperkalemia). |
| Digoxin (cardiac glycoside) (Cardiac glycosides) | theoretical | Diuretic-induced electrolyte changes (particularly hypokalemia, though less likely with potassium-rich horsetail than with pharmaceutical diuretics) could potentiate the toxic effects of digoxin. Digoxin toxicity is enhanced by hypokalemia, hypomagnesemia, and hypercalcemia. |
| Anticoagulant and antiplatelet medications (warfarin, heparin, aspirin, clopidogrel) (Anticoagulants and antiplatelets) | theoretical | Theoretical concern based on the thiaminase content of improperly prepared raw horsetail. Thiamine deficiency can impair hepatic synthesis of coagulation factors, potentially potentiating anticoagulant effects. However, this mechanism is only relevant to raw, unprocessed plant material and is not a concern with properly prepared products where thiaminase has been heat-inactivated. |
| Anti-retroviral medications (some protease inhibitors, NRTIs) (Anti-retrovirals) | theoretical | Theoretical concern that the thiaminase in raw horsetail could exacerbate thiamine deficiency, which is already prevalent in HIV patients on certain anti-retroviral regimens. This is only relevant to unprocessed plant material. |
Pregnancy & Lactation
Pregnancy
insufficient data
Lactation
insufficient data
There is insufficient safety data on the use of Equisetum arvense during pregnancy and lactation. No controlled studies in pregnant or breastfeeding women have been conducted. The EMA assessment report notes that traditional use data do not include specific evidence of safety during pregnancy or lactation. The diuretic action raises theoretical concerns about fluid and electrolyte balance during pregnancy. Some references classify horsetail as AHPA class 2b ('not to be used during pregnancy'), though this classification is precautionary rather than based on documented teratogenicity or reproductive toxicity. As a precautionary measure, therapeutic doses of horsetail should be avoided during pregnancy and breastfeeding unless specifically recommended by a qualified practitioner. Occasional use as a brief tea is likely low-risk but has not been formally studied.
Adverse Effects
References
Monograph Sources
- [1] German Federal Institute for Drugs and Medical Devices (BfArM), Commission E. Monograph: Equiseti herba (Horsetail herb). Bundesanzeiger (Federal Gazette), No. 173 (1988)
- [2] European Medicines Agency (EMA), Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Equisetum arvense L., herba. EMA/HMPC/278091/2015 (2016)
- [3] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds.). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX / Integrative Medicine Communications, Boston, MA (1998)
- [4] Weiss RF, Fintelmann V. Herbal Medicine (2nd revised edition). Thieme, Stuttgart/New York (2001)
- [5] Felter HW, Lloyd JU. King's American Dispensatory (18th edition, 3rd revision). Ohio Valley Company, Cincinnati (1898)
- [6] Badole S, Kotwal S. Equisetum arvense: Ethanopharmacological and Phytochemical review with reference to osteoporosis. Int J Pharm Sci Health Care (2014) ; 1 : 131-141
Clinical Studies
- [7] Carneiro DM, Freire RC, Honorio TC, Zoghaib I, Cardoso FF, Tresvenzol LM, de Paula JR, Sousa AL, Jardim PC, da Cunha LC. Randomized, double-blind clinical trial to assess the acute diuretic effect of Equisetum arvense (field horsetail) in healthy volunteers. Evid Based Complement Alternat Med (2014) ; 2014 : 760683 . DOI: 10.1155/2014/760683 . PMID: 24688592
- [8] Corletto F. Female climacteric osteoporosis therapy with titrated horsetail (Equisetum arvense) extract plus calcium (preliminary report). Minerva Ortopedica e Traumatologica (1999) ; 50 : 201-206
- [9] Sandhu NS, Kaur S, Chopra D. Equisetum arvense: pharmacology and phytochemistry — a review. Asian J Pharm Clin Res (2010) ; 3 : 146-150
- [10] Carneiro DM, Tresvenzol LM, Jardim PC, da Cunha LC. Equisetum arvense: scientific evidence for clinical use. Naturwissenschaften (2009) ; 96 : 231-238
Traditional Texts
- [11] Pedanius Dioscorides. De Materia Medica (Peri Hyles Iatrikes). Original text ca. 50-70 CE; multiple modern translations including Gunther (1934) and Osbaldeston (2000) (65)
- [12] Gaius Plinius Secundus (Pliny the Elder). Naturalis Historia (Natural History). Original text ca. 77-79 CE; multiple modern translations including Rackham (Loeb Classical Library) (77)
- [13] Moerman DE. Native American Ethnobotany. Timber Press, Portland, OR (1998)
Pharmacopeias & Reviews
- [14] European Directorate for the Quality of Medicines & HealthCare (EDQM). European Pharmacopoeia, 11th edition: Equiseti herba (Horsetail). Council of Europe, Strasbourg (2023)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.